Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Embozene® Microspheres for Uterine Fibroid Embolization Compared to Embosphere® Microspheres for Symptomatic Relief From Uterine Fibroids

NCT02884960 is registered in ClinicalTrials.gov with Gary Siskin, MD as lead sponsor.

NCT NCT02884960
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02884960 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Embozene® Microspheres for Uterine Fibroid Embolization Compared to Embosphere® Microspheres for Symptomatic Relief From Uterine Fibroids
Lead sponsor
Gary Siskin, MD
Phase
Not applicable
Overall status
Unknown status
Start date
October 31, 2016
Completion date
October 31, 2018
Enrollment
118 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

uterine fibroids